2,529 followers
Open Access UCL Research: An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma https://t.co/T2y0yh8AKL
Open Access UCL Research: An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma https://t.co/T2y0yh8AKL
I seem to have had another paper published. #Radiosensitisers and #neuroblastoma https://t.co/OJF5hN7veM